Canadian Drug Pricing Reforms Could Lead To Medicine Shortages
Executive Summary
Drug pricing reform in Canada could prompt companies to launch elsewhere or see drugs diverted to the US.
You may also be interested in...
Canada Pulls Controversial Pricing Measures
Some measures aimed at reducing medicine prices in Canada have been dropped, to the relief of the pharmaceutical industry.
COVID-19 Pandemic Means Another Delay For Canadian Pricing Reforms
Industry has have welcomed another delay to the implementation of drug pricing reforms that aim to lower Canadian drugs prices.
Pricing Reforms Prompt Canadian Business Rethink
The R&D based pharmaceutical industry would welcome changes to guidelines that will operationalize controversial new pricing regulations in Canada but industry experts say more is needed.